No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs6823378 |
chr4:8315938-8315939 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs573695753 |
chr4:8315942-8315943 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs74824513 |
chr4:8315964-8315965 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs375557682 |
chr4:8315983-8315984 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs562893241 |
chr4:8315984-8315985 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs181675889 |
chr4:8315989-8315990 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs114536582 |
chr4:8316023-8316024 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs111762968 |
chr4:8316042-8316043 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs143499293 |
chr4:8316061-8316062 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs527682500 |
chr4:8316102-8316103 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs549437555 |
chr4:8316111-8316112 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs4696679 |
chr4:8316128-8316129 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs531658313 |
chr4:8316142-8316143 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs372950395 |
chr4:8316143-8316144 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs151187602 |
chr4:8316156-8316157 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs568926595 |
chr4:8316187-8316188 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs4696680 |
chr4:8316215-8316216 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs7667031 |
chr4:8316225-8316226 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs140325116 |
chr4:8316250-8316251 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs533536437 |
chr4:8316255-8316256 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs555022713 |
chr4:8316261-8316262 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs567257746 |
chr4:8316285-8316286 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs537509895 |
chr4:8316291-8316292 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs556257680 |
chr4:8316323-8316324 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs13110948 |
chr4:8316338-8316339 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs530070328 |
chr4:8316350-8316351 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs4696681 |
chr4:8316436-8316437 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs28664747 |
chr4:8316494-8316495 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
29 |
rs377630434 |
chr4:8316513-8316514 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs4696682 |
chr4:8316529-8316530 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
31 |
rs4696683 |
chr4:8316535-8316536 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs150214715 |
chr4:8316603-8316604 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs4235263 |
chr4:8316621-8316622 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs4463054 |
chr4:8316699-8316700 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs367769387 |
chr4:8316727-8316728 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs575515581 |
chr4:8316728-8316729 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs185384384 |
chr4:8316780-8316781 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs188426317 |
chr4:8316799-8316800 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs566339443 |
chr4:8316836-8316837 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs527536769 |
chr4:8316844-8316845 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs113402569 |
chr4:8316877-8316878 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs549282325 |
chr4:8316902-8316903 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs567136232 |
chr4:8316910-8316911 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs181242822 |
chr4:8316912-8316913 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs555982122 |
chr4:8316916-8316917 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs199990071 |
chr4:8316927-8316928 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs201410351 |
chr4:8316928-8316929 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs112730011 |
chr4:8316929-8316930 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs112035725 |
chr4:8316930-8316931 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs76332381 |
chr4:8316995-8316996 |
Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|